These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34389117)

  • 1. Mood and emotional disorders associated with parkinsonism, Huntington disease, and other movement disorders.
    Bono AD; Twaite JT; Krch D; McCabe DL; Scorpio KA; Stafford RJ; Borod JC
    Handb Clin Neurol; 2021; 183():175-196. PubMed ID: 34389117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extrapyramidal disorders: interest of myoclonus analysis].
    Defebvre L
    Rev Neurol (Paris); 2007 Nov; 163(11):1115-21. PubMed ID: 18033054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuropsychiatry of Parkinson's disease and related disorders.
    Lauterbach EC
    Psychiatr Clin North Am; 2004 Dec; 27(4):801-25. PubMed ID: 15550293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical manifestations of Parkinson's disease and parkinsonism.
    Hobson DE
    Can J Neurol Sci; 2003 Mar; 30 Suppl 1():S2-9. PubMed ID: 12691471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmotor Features in Atypical Parkinsonism.
    Bhatia KP; Stamelou M
    Int Rev Neurobiol; 2017; 134():1285-1301. PubMed ID: 28805573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive epidemiology of parkinsonism in the Canton of Geneva, Switzerland.
    Fleury V; Brindel P; Nicastro N; Burkhard PR
    Parkinsonism Relat Disord; 2018 Sep; 54():30-39. PubMed ID: 29661694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):1-31. PubMed ID: 19523490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of psychiatric disturbances in hypokinetic movement disorders.
    Berardelli I; Belvisi D; Pasquini M; Fabbrini A; Petrini F; Fabbrini G
    Expert Rev Neurother; 2019 Oct; 19(10):965-981. PubMed ID: 31241368
    [No Abstract]   [Full Text] [Related]  

  • 10. Olfaction in neurodegenerative disorder.
    Hawkes C
    Adv Otorhinolaryngol; 2006; 63():133-151. PubMed ID: 16733338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Impairment in Neurodegenerative Movement Disorders.
    Abdelnour C; Poston KL
    Semin Neurol; 2023 Feb; 43(1):81-94. PubMed ID: 36940727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders.
    Peralta C; Biafore F; Depetris TS; Bastianello M
    Curr Neurol Neurosci Rep; 2019 Jun; 19(8):56. PubMed ID: 31256288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A differential diagnosis of Parkinsonism.
    Weiner WJ
    Rev Neurol Dis; 2005; 2(3):124-31. PubMed ID: 16400311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Genetic Landscape of Parkinsonism-Related Dystonias and Atypical Parkinsonism-Related Syndromes.
    Diez-Fairen M; Alvarez Jerez P; Berghausen J; Bandres-Ciga S
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFFECT OF ALPHA-METHYL DOPA AND RESERPINE IN HUNTINGTON'S CHOREA, PARKINSON'S DISEASE AND OTHER MOVEMENT DISORDERS.
    MARKHAM CH; CLARK WG; WINTERS WD
    Life Sci (1962); 1963 Sep; 9():697-705. PubMed ID: 14068044
    [No Abstract]   [Full Text] [Related]  

  • 17. Parkinson's Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonism.
    van Rumund A; Aerts MB; Esselink RAJ; Meijer FJA; Verbeek MM; Bloem BR
    BMC Neurol; 2018 May; 18(1):69. PubMed ID: 29764386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognition and emotion in different stages and subtypes of Parkinson's disease.
    Stocchi F; Brusa L
    J Neurol; 2000 Apr; 247 Suppl 2():II114-21. PubMed ID: 10991658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of Parkinson's disease and other neurodegenerative disorders.
    Koh J; Ito H
    Nihon Rinsho; 2017 Jan; 75(1):56-62. PubMed ID: 30566295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.